ATM and COVID-19: However, as our other SARS-CoV-2 infected A-T patients, including those with a HIgM phenotype, did not have severe COVID-19 (Table S4), the ATM mutation identified here is probably underlying the primary antibody deficiency (HIgM) in this patient, but not the critical COVID-19.